Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001193805-22-001600
Filing Date
2022-11-22
Accepted
2022-11-23 11:26:21
Documents
6

Document Format Files

Seq Description Document Type Size
1 e618050_prec14a-dpi.htm PREC14A 311717
2 GRAPHIC image_001.jpg GRAPHIC 5638
3 GRAPHIC image_002.jpg GRAPHIC 5647
4 GRAPHIC image_003.jpg GRAPHIC 11494
5 GRAPHIC image_004.jpg GRAPHIC 18296
6 GRAPHIC image_005.jpg GRAPHIC 11728
  Complete submission text file 0001193805-22-001600.txt   386862
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Subject) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-37942 | Film No.: 221414398
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address 250 WEST 55TH STREET NEW YORK NY 10019 212-915-2565
LifeSci Management Co LLC (Filed by) CIK: 0001955680 (see all company filings)

EIN.: 000000000
Type: PREC14A